Bemnifosbuvir (BEM)
AT-03A-017
Phase 3 small_molecule completed
Quick answer
Bemnifosbuvir (BEM) for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2 Infection) is a Phase 3 program (small_molecule) at Atea Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atea Pharmaceuticals
- Indication
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2 Infection)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed